The Efficacy of Hypnotic Cognitive Therapy for Chronic Pain in SCI
CompletedNot applicableNCT03857672
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Chronic pain is prevalent and disabling in people with spinal cord injury (SCI). Medications alone often do not cure the pain. Pilot research suggests that training in the combination of self-hypnosis and cognitive therapy (HCT) can reduce chronic SCI-related pain. Thus far, people have learned HCT only through in-person training sessions plus home practice. The investigators think that training in HCT could be as effective if the training is done via videoconferencing. The purpose of this study is to find out whether people who are trained in HCT via videoconferencing achieve significant pain relief and other benefits compared to people who receive usual medical care (UC) for pain. Bettering our understanding of videoconferencing-delivered HYPNOCT can greatly increase treatment accessibility for individuals with SCI. Aim 1: To compare the efficacy of HYPNOCT vs. UC in adults with SCI and chronic pain. Investigators will compare the effect of the intervention on patient-reported average daily pain as measured by a 0-10 numerical rating scale. Aim 2: To examine sex, race/ethnicity, and pain type (neuropathic vs. non-neuropathic) as potential effect modifiers. Hypotheses Primary study hypothesis Hypothesis 1a: There will be a significantly greater reduction in average daily pain intensity from baseline to the end of treatment in the HYPNOCT group compared to the UC group. Secondary study hypotheses Hypothesis 1b: Compared to the UC group, participants in the HYPNOCT group will show greater improvement in pain interference, depression, sleep quality, subjective disability, health-related quality of life, community participation, pain catastrophizing, pain acceptance, and global improvement. Hypothesis 2: The investigators will examine whether sex, race/ethnicity, and pain type (neuropathic vs. non-neuropathic) exert a modifying effect upon outcomes.
Study details
- Official title
- The Efficacy of Hypnotic Cognitive Therapy for Chronic Pain in SCI
- Conditions
- Interventions
- Behavioral: Hypnotic Cognitive Therapy (HYPNOCT)
- Sponsor
- University of Washington
- Collaborators
- The Craig H. Neilsen Foundation
- Start date
- 2019-04-24
- Primary completion
- 2022-03-31
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: 1. Adults aged 18 years or older; 2. diagnosis of SCI at any level or severity; 3. completed inpatient rehabilitation (to ensure diagnosis and sufficient severity of SCI); 4. of ≥ 4 on a 0-10 NRS of pain intensity in the last week (during both the screening and baseline examinations) 5. reports that pain interferes with general activities (rates pain interference ≥ 1 on 0-10 scale) 6. reports pain has been present 12 weeks or more (chronic); 7. reports being able to read and speak English. 8. Have access to a webcam \& microphone through either a computer, smartphone, or other internet-connected device. Exclusion Criteria: 1. Severe cognitive impairment defined as one or more errors on the Six-Item Screener; 2. presence or history of mental health problems that would require referral for more intensive treatment or complicate hypnotic treatment (current suicidal ideation with intent or plan to harm oneself, current drug or alcohol dependence, lifetime history of bipolar disorder, psychosis, paranoid disorder based on screening questions from the M.I.N.I Neuropsychiatric Interview; 3. primary chronic pain problem pre-dated SCI (e.g., chronic headache); 4. has not undergone a previous medical evaluation for their pain to rule out treatable causes or undiagnosed disease (e.g., cancer); 5. unstable pain medication regimen (dosage changes within the past 3 weeks); 6. currently receiving CT or hypnosis for pain or has failed prior treatment with CT or hypnosis; and 7. declines to provide informed consent.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT03857672